3/13/2014

The abundance of media coverage and public interest in human papillomavirus vaccination in the months after the Food and Drug Administration's approval of Gardasil was strongly related to the increase in human papillomavirus vaccine-associated adverse events reported to the Vaccine Adverse Event Reporting System.

Related Summaries